Pure Global

BAUSCH & LOMB AMVISC PLUS INJECTION 16 mg/ml - HSA Registration DE0006725

Access comprehensive regulatory information for BAUSCH & LOMB AMVISC PLUS INJECTION 16 mg/ml in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0006725 and owned by Bausch & Lomb Incorporated. The device was registered on May 16, 2011.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free Database
Powered by Pure Global AI
HSA Official Data
CLASS D
DE0006725
BAUSCH & LOMB AMVISC PLUS INJECTION 16 mg/ml
HSA Registration Number: DE0006725
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Description

For use as a surgical aid in ophthalmic anterior and posterior segment procedures.

Device Classification
Device Class
CLASS D
Medical Speciality Area
Ophthalmology
Registration Information
Registration Number
DE0006725
Registration Date
May 16, 2011
Change Notification Approval Date
October 29, 2024
Retention Due Date
January 15, 2026
Product Owner
Short Name
Bausch & Lomb
Address
1400 North Goodman Street, Rochester, NY 14609, UNITED STATES
Registrant
Address
3 HARBOURFRONT PLACE, HARBOURFRONT TOWER TWO, #09-04, SINGAPORE 099254
Importer
Address
3 HARBOURFRONT PLACE, HARBOURFRONT TOWER TWO, #09-04, SINGAPORE 099254
Model Information
Model Name(s)
AMVISC PLUS INJECTION 16 mg/ml (1 x 0.8ml)
Model Identifier(s)
60081L